Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
08/2000
08/31/2000WO2000012074A3 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
08/31/2000DE10008042A1 Neurokinin-1-Rezeptorantagonisten Neurokinin-1 receptor antagonists
08/31/2000CA2366951A1 Methods and compositions for altering mucus secretion
08/31/2000CA2364653A1 Pde iv inhibiting compounds, compositions and methods of treatment
08/31/2000CA2362928A1 Vaccine for house dust mite allergen using naked plasmid dna
08/31/2000CA2362906A1 Dna encoding snorf25 receptor
08/31/2000CA2362533A1 Gene sequence variations with utility in determining the treatment of disease
08/30/2000EP1031348A2 Interleukin-4 production inhibitors
08/30/2000EP1031347A1 Transnasal transport/immunisation with highly adaptable carriers
08/30/2000EP1030911A1 Human aspartic proteases
08/30/2000EP1030845A1 Heterocyclic compounds having mmp and tnf inhibitory activity
08/30/2000EP1030840A1 Cyclic amine derivatives and their use as drugs
08/30/2000EP1030836A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
08/30/2000EP1030835A2 Urea derivatives and their use as integrin inhibitors
08/30/2000EP1030683A1 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions
08/30/2000EP1030667A1 Use of mirtazapine for treating sleep apneas
08/30/2000EP1030664A1 Pharmaceutical compositions containing zafirlukast
08/30/2000EP1030662A2 Treatment of t-helper cell type 2 mediated immune diseases with retinoid antagonists
08/30/2000EP1030661A1 N,N-DIETHYLGLYCOLAMIDO ESTER PRODRUGS OF INDOLE sPLA 2? INHIBITORS
08/30/2000EP0836606B1 Condensed thiazole derivatives, having 5-ht receptor affinity
08/30/2000EP0799198B1 Anti-inflammatory compounds
08/30/2000EP0584290B1 Endothelin antagonists
08/30/2000CN1265114A Method for large-scale production of Di (uridine 5'-tetraphosphate) and salts thereof
08/30/2000CN1265102A Benzothia (oxa) diazol derivatives and their use as endothelin-receptor antagonists
08/30/2000CN1264588A Powdered 'Yanhouling' medicine and preparing process thereof
08/30/2000CN1055841C External adhesive plaster for treating infantile pneumonia and prepn. method for same external adhesive plaster
08/29/2000US6111078 Staphylococcus aureus rsbU-1
08/29/2000US6110964 For treating arthritis, inflammatory bowel disease, crohn's disease, emphysema, acute respiratory distress syndrome, asthma chronic obstructive pulmonary disease, alzheimer's disease, organ transplant toxicity, cachexia, cancer
08/29/2000US6110952 Preventing or treating nasal congestion, otitis media and sinusitis without undesired side effects, also asthma, pain, migraine, substance abuse and addiction, gastrointestinal disorder, ulcer, stomach hyperacidity
08/29/2000US6110944 LTA4, hydrolase inhibitors
08/29/2000US6110939 As a substance p antagonists treating tachykinin-mediated disease, asthma, central nervous system disorder
08/29/2000US6110933 Amino acid derivatives and their use as phospholipase A2 inhibitor
08/24/2000WO2000049147A1 Hormone-hormone receptor complexes and nucleic acid constructs and their use in gene therapy
08/24/2000WO2000049015A1 Pyridine compounds and their pharmaceutical use
08/24/2000WO2000049008A1 Di- and tripeptide nitrile derivatives as inhibitors of cathepsin l and cathepsin s
08/24/2000WO2000049007A1 Acetamido acetonitrile derivatives as inhibitors of cathepsin l and/or cathepsin s
08/24/2000WO2000049005A1 Bicyclic compounds and their use as integrin receptor ligands
08/24/2000WO2000048994A1 Thioamide derivatives
08/24/2000WO2000048992A1 Acylated aminoacetonitriles as cysteine protease inhibitors
08/24/2000WO2000048989A1 Mevinolin derivatives
08/24/2000WO2000048988A1 Phenylalaninol derivatives
08/24/2000WO2000048626A2 Aerosol compositions of hmg-coa reductase inhibitors for inhibiting inflammation associated with pulmonary disease
08/24/2000WO2000048624A2 Utilization of orosomucoid in order to produce a pharmaceutical preparation
08/24/2000WO2000048623A1 Novel amide derivatives as growth hormone secretagogues
08/24/2000WO2000048593A1 Epoxide hydrolase complexes and methods therewith
08/24/2000WO2000048587A1 Combinations of formoterol and fluticasone propionate for asthma
08/24/2000WO2000037470A8 Antihistaminic spiro compounds
08/24/2000WO2000022113A9 ENZYMATIC SYNTHESIS OF ssDNA
08/24/2000WO2000015797A3 Compositions and methods for the treatment of immune related diseases
08/24/2000WO2000015246A9 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto
08/24/2000WO2000010536A9 Extended release buccal bioadhesive tablet
08/24/2000DE4193302C2 Verwendung rekombinanter Antikörper spezifisch für TNF-alpha Using recombinant antibody specific for TNF-alpha
08/24/2000CA2368537A1 Combinations of formoterol and fluticasone propionate for asthma
08/24/2000CA2362970A1 Hormone-hormone receptor complexes and nucleic acid constructs and their use in gene therapy
08/24/2000CA2362862A1 Bicyclic compounds and their use as integrin receptor ligands
08/24/2000CA2362664A1 Utilization of orosomucoid in order to produce a pharmaceutical preparation
08/24/2000CA2362538A1 Secreted proteins and polynucleotides encoding them
08/24/2000CA2362290A1 Novel amide derivatives as growth hormone secretagogues
08/23/2000EP1029869A1 Endothelin converting enzyme inhibitors
08/23/2000EP1029550A1 Preventives and remedies for diffuse lung diseases
08/23/2000EP1028957A1 Piperidine derivatives and their use as tachykinin antagonists
08/23/2000EP1028946A1 Indazole bioisostere replacement of catechol in therapeutically active compounds
08/23/2000EP1028945A1 Substituted pyridine compounds as anti-inflammatory agents
08/23/2000EP0711289B1 Piperazine compounds used in therapy
08/23/2000CN1264425A Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy
08/23/2000CN1264383A Salts of optically active sulfoxide derivative
08/23/2000CN1264382A Novel compounds
08/23/2000CN1264381A 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide Y receptor antagonists
08/23/2000CN1264378A Quinoline-4-carboxamide derivatives as NK-2 and NK-3 receptor antagonists
08/23/2000CN1264377A Substituted pyrazoles as P38 kinase inhabitors
08/23/2000CN1264376A 3(5)-Heteroaryl substituted pyrazoles as P38 kinase inhibitors
08/23/2000CN1263945A American pig reproduction and respiratory syndrome (PRRS) virus and its use
08/23/2000CN1263889A Monoclinic system sheet crystal tazhanot
08/22/2000US6107473 Kringle-related clone HTHBZ47
08/22/2000US6107334 Dietary control of arachidonic acid metabolism
08/22/2000US6107331 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
08/22/2000US6107291 Antiinflammatory agent
08/22/2000US6106858 Loading active materials of liposomes by dissolving
08/22/2000CA2176973C Phenyl heterocycles as cyclooxygenase-2 inhibitors
08/22/2000CA2111002C Non-chlorofluorocarbon aerosol formulations
08/22/2000CA2016627C Proteinase inhibitors, process for the preparation thereof and medicaments containing these
08/17/2000WO2000047625A2 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
08/17/2000WO2000047623A1 Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant
08/17/2000WO2000047620A1 Cytokine-binding domain
08/17/2000WO2000047619A1 Therapeutics and diagnostics based on an il-1b mutation
08/17/2000WO2000047611A2 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor
08/17/2000WO2000047602A1 33 human secreted proteins
08/17/2000WO2000047583A1 Cyclic substituted fused pyrrolocarbazoles and isoindolones
08/17/2000WO2000047580A2 Phenyl urea and phenyl thiourea derivatives
08/17/2000WO2000047578A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors
08/17/2000WO2000047572A1 (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same
08/17/2000WO2000047562A1 Spirocyclic ketones and their use as tachykinin antagonists
08/17/2000WO2000047554A2 INHIBITORS OF FACTOR Xa
08/17/2000WO2000047553A2 ALKENYL AND ALKYNYL COMPOUNDS AS INHIBITORS OF FACTOR Xa
08/17/2000WO2000047215A2 Methods for anti-tumor therapy
08/17/2000WO2000047200A1 Combinations of formoterol and a tiotropium salt
08/17/2000WO2000047194A2 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR
08/17/2000WO2000012076A9 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
08/17/2000CA2362592A1 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
08/17/2000CA2362390A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors